Saudi Arabia: SFDA Introduces New Permit Service for Travellers Carrying Controlled Drugs

The Saudi Food and Drug Authority (SFDA) has launched a new service aimed at streamlining the process for travelers carrying controlled drugs into and out of the Kingdom of Saudi Arabia. CEO of SFDA, H.E. Prof. Hisham bin Saad Al-Jadhei, officially introduced the Permit for Travelers to Possess Controlled Drugs service.

Seamless Experience for Travelers

This initiative is designed to enhance travelers’ experiences by allowing them to declare in advance their possession of controlled medications. Through the Restricted Drugs System (https://cds.sfda.gov.sa/), travelers can submit the required documents detailing the type and quantity of drugs, the length of stay, and other relevant information. The SFDA will then review the submissions to ensure compliance with regulations before issuing the necessary permits. These permits must be presented upon arrival at transit points and during the traveler’s stay in the Kingdom.

How Travelers Can Apply

For travelers planning to visit or depart from Saudi Arabia with controlled drugs, the process is straightforward:

Strengthening Compliance and Control

Beyond simplifying the entry and exit process, the service plays a crucial role in regulating the use of controlled substances. By integrating with relevant government agencies, it ensures that only authorized individuals or their legal representatives can carry such drugs. This initiative aligns with both local and international regulations, preventing misuse and enhancing public safety.

Boosting Tourism and Economic Growth

Saudi Arabia’s new permit system also supports the Kingdom’s broader goals under Vision 2030, which aim to enhance the country’s global standing as a key tourist destination. By reducing bureaucratic hurdles, the service makes it easier for international visitors to bring necessary medications while ensuring legal compliance. This step will contribute to a more welcoming and efficient travel environment, positioning Saudi Arabia as a medical tourism hub.

Conclusion

The introduction of this new permit service marks a significant step towards enhancing regulatory control while improving traveler convenience. By prioritizing both safety and accessibility, Saudi Arabia is paving the way for a more seamless and secure travel experience for those requiring controlled medications.

For more information and assistance in applying for permits, please contact us at info@arqon.com

Source: Saudi Food & Drug Authority (SFDA)